|
|
||||||||
The Annals of Thoracic Surgery, Vol 55, 25-30, Copyright © 1993 by The Society of Thoracic Surgeons
DG Crescenzo, SL Hilbert, RH Messier Jr, PW Domkowski, MK Barrick, PL Lange, VJ Ferrans, RB Wallace and RA Hopkins
Twenty-five human cryopreserved valves with harvest-related warm ischemic
times (WITs) ranging from 0 to 20 hours were studied using transmission
electron microscopy to characterize the effects of harvesting and
preservation on leaflet matrix cells. The valves were divided into seven
groups on the basis of WIT and processed using standard transmission
electron microscopic methods. Each cell (528 micrographs) was graded for
reversible and irreversible cellular injury and subjected to a
Cochran-Mantel-Haenszel trend analysis. Our results demonstrated a
progression in cellular injury with increasing WIT. During the first 12
hours of warm ischemia, reversible cellular injury predominated (0.0%,
30.0%, 51.2%, 31.3%, 35.1%, 45.1%, and 40.0% at WITs of 0, 1, 2, 8, 12, 16,
and 20 hours, respectively). A positive correlation (p < 0.0001) between
increasing WIT and reversible cellular injury through the first 12 hours
was observed. Minimal morphologic evidence of irreversible injury was noted
in valves harvested with less than 12 hours of warm ischemia; however,
after 12 hours there was a marked increase (0.0%, 0.0%, 4.7%, 2.4%, 2.7%,
31.4%, and 40.0% at WITs of 0, 1, 2, 8, 12, 16, and 20 hours, respectively)
in irreversible cellular injury (p < 0.001 between 12 and 20 hours WIT).
These data demonstrate a progression in cellular injury with increasing
WIT. There was virtually no morphologic injury in valves with
harvest-related WITs less than 2 hours and minimal irreversible cellular
injury observed in valves exposed to 12 hours or less of warm ischemia. If
cellular viability is critical to homograft durability then harvest-related
warm ischemia may need to be restricted to 12 hours.
ARTICLES
Human cryopreserved homografts: electron microscopic analysis of cellular injury
Georgetown University School of Medicine, Washington, DC.
This article has been cited by other articles:
![]() |
Y. C. Song, L. Y. Yao, J. M. Kneebone, and F. M. Lupinetti EFFECT OF CRYOPRESERVATION AND HISTOCOMPATIBILITY ON TYPE I PROCOLLAGEN GENE EXPRESSION IN AORTIC VALVE GRAFTS J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 421 - 427. [Abstract] [Full Text] |
||||
![]() |
C. Wassenaar, W. A. Bax, R.-J. van Suylen, V. D. Vuzevski, and E. Bos EFFECTS OF CRYOPRESERVATION ON CONTRACTILE PROPERTIES OF PORCINE ISOLATED AORTIC VALVE LEAFLETS AND AORTIC WALL J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 165 - 172. [Abstract] [Full Text] |
||||
![]() |
R. J. Baskett, D. B. Ross, M. A. Nanton, and D. A. Murphy FACTORS IN THE EARLY FAILURE OF CRYOPRESERVED HOMOGRAFT PULMONARY VALVES IN CHILDREN: PRESERVED IMMUNOGENICITY? J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1170 - 1179. [Abstract] [Full Text] |
||||
![]() |
M. G. Hazekamp, D. R. Koolbergen, J. Braun, H. Sugihara, C. J. Cornelisse, Y. A. Goffin, and H. A. Huysmans In situ hybridization: A new technique to determine the origin of fibroblasts in cryopreserved aortic homograft valve explants J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 248 - 257. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |